Guru Ownership Trend
Guru Analysis for Supernus Pharmaceuticals, Inc. (SUPN)
Supernus Pharmaceuticals, Inc. (SUPN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $86.34 M.
Top institutional holders include Renaissance Technologies (RenTech) and Robert Bruce.
Institutional sentiment is currently Bearish. This is evidenced by a $84.19 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Chuck Royce reduced exposure by 82.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Supernus Pharmaceuticals, Inc. (SUPN)
Major holders include Renaissance Technologies (RenTech) ($68.75 M), Robert Bruce ($6.98 M), Cliff Asness ($4.13 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 1.79 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $84.19 M, with 4 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited SUPN. The total reported sell value was $88.01 M.
Yes, 3 managers opened new positions in SUPN, and 1 increased their existing holdings. The total reported buy value was $3.82 M.
